Correlation between synovial fluid and serum IL-1β levels after ACL surgery–preliminary report
- 27 August 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in International Orthopaedics
- Vol. 33 (2), 413-418
- https://doi.org/10.1007/s00264-008-0649-1
Abstract
The possibility of controlling the harmful intra-articular influence of elevated interleukin (IL)-1β synovial fluid concentration after anterior cruciate ligament (ACL) surgery could be useful. We investigated the correlation between serum and synovial fluid IL-1β levels following ACL reconstruction. We measured IL-1β concentration periodically in three synovial fluid and four serum samples in each of 20 patients receiving either autologous conditioned serum (ACS) containing endogenous anti-inflammatory cytokines including IL-1Ra and several growth factors (group A) or placebo (group B). A decrease in IL-1β synovial fluid concentration appeared to be more pronounced in absolute terms in group A. In eight patients serum IL-1β was detected on the 6th postoperative day. In four of them whose synovial fluid levels were over 10 pg/ml on the 6th postoperative day, serum IL-1β was detected on the 10th postoperative day. The results were different in group B. Correlation between serum and synovial fluid IL-1β appearance persists in patients after ACL surgery and ACS application. This study is an example of ACS influence on the ACL healing process controlling the IL-1β levels on the basis of the serum IL-1β detection.Keywords
This publication has 27 references indexed in Scilit:
- Biological mechanisms of bone and cartilage remodelling—genomic perspectiveInternational Orthopaedics, 2007
- Plasma Cytokines as Markers of Aseptic Prosthesis LooseningClinical Orthopaedics & Related Research, 2006
- Bone Morphogenetic Protein–7 (Osteogenic Protein–1) Promotes Tendon Graft Integration in Anterior Cruciate Ligament Reconstruction in SheepThe American Journal of Sports Medicine, 2004
- Osteolysis: Basic ScienceClinical Orthopaedics and Related Research, 2001
- The Role of the Interleukin-1–Receptor Antagonist in Blocking Inflammation Mediated by Interleukin-1New England Journal of Medicine, 2000
- In Vivo Transfer of Interleukin-1 Receptor Antagonist Gene in Osteoarthritic Rabbit Knee JointsThe American Journal of Pathology, 1999
- The Natural History of the Anterior Cruciate Ligament-Deficient KneeThe American Journal of Sports Medicine, 1997
- Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of OsteoporosisNew England Journal of Medicine, 1995
- Interleukin-1 Receptor AntagonistAdvances in Immunology, 1993
- Normal Ligament Properties and Ligament HealingPublished by Ovid Technologies (Wolters Kluwer Health) ,1985